Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Marks

Showing results (991-1000 of 1,089) with videos related to

Pageof 109
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2012
Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG studyThanyanan Reungwetwattana, Julian R Molina, Sumithra J Mandrekar, et al.
Clinical Chemistry|April 22, 2006
APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancerJack Groskopf, Sheila M J Aubin, Ina Lim Deras, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Phase I trial of sirolimus combined with radiation and cisplatin in non-small cell lung cancerJann N Sarkaria, Paul Schwingler, Steven E Schild, et al.
AJR. American Journal of Roentgenology|May 1, 2019
Utility of Restriction Spectrum Imaging Among Men Undergoing First-Time Biopsy for Suspected Prostate CancerEly R Felker, Steven S Raman, Sepideh Shakeri, et al.
Cancer|October 24, 1997
The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvementT E Sawyer, J A Bonner, P M Gould, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinomaJ A Bonner, J A Sloan, T G Shanahan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2005
Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732Harvey B Niell, James E Herndon, Antonius A Miller, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancerSteven E Schild, Philip J Stella, Susan M Geyer, et al.
Hepatology (Baltimore, Md.)|August 14, 2009
Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trialStuart K Roberts, Martin D Weltman, Darrell H G Crawford, et al.
Molecular Cell|April 14, 2015
PTEN functions by recruitment to cytoplasmic vesiclesAdam Naguib, Gyula Bencze, Hyejin Cho, et al.
Pageof 109

Showing results (991-1000 of 1,089) with videos related to

Sort By:
Pageof 109
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2012
Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG studyThanyanan Reungwetwattana, Julian R Molina, Sumithra J Mandrekar, et al.
Clinical Chemistry|April 22, 2006
APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancerJack Groskopf, Sheila M J Aubin, Ina Lim Deras, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Phase I trial of sirolimus combined with radiation and cisplatin in non-small cell lung cancerJann N Sarkaria, Paul Schwingler, Steven E Schild, et al.
AJR. American Journal of Roentgenology|May 1, 2019
Utility of Restriction Spectrum Imaging Among Men Undergoing First-Time Biopsy for Suspected Prostate CancerEly R Felker, Steven S Raman, Sepideh Shakeri, et al.
Cancer|October 24, 1997
The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvementT E Sawyer, J A Bonner, P M Gould, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinomaJ A Bonner, J A Sloan, T G Shanahan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2005
Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732Harvey B Niell, James E Herndon, Antonius A Miller, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancerSteven E Schild, Philip J Stella, Susan M Geyer, et al.
Hepatology (Baltimore, Md.)|August 14, 2009
Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trialStuart K Roberts, Martin D Weltman, Darrell H G Crawford, et al.
Molecular Cell|April 14, 2015
PTEN functions by recruitment to cytoplasmic vesiclesAdam Naguib, Gyula Bencze, Hyejin Cho, et al.
Pageof 109